IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination

Lorenz Thurner; Christoph Kessel; Natalie Fadle; Evi Regitz; Franziska Seidel; Ingrid Kindermann; Stefan Lohse; Igor Kos; Carsten Tschöpe; Parastoo Kheiroddin; Daniel Kiblboeck; Marie-Christin Hoffmann; Birgit Bette; Gabi Carbon; Onur Cetin; Klaus-Dieter Preuss; Konstantinos Christofyllakis; Joerg T. Bittenbring; Thomas Pickardt; Yvan Fischer; Holger Thiele; Stephan Baldus; Karl Stangl; Stephan Steiner; Frank Gietzen; Sebastian Kerber; Thomas Deneke; Stefanie Jellinghaus; Axel Linke; Karim Ibrahim; Ulrich Grabmaier; Steffen Massberg; Christian Thilo; Simon Greulich; Meinrad Gawaz; Ertan Mayatepek; Lars Meyer-Dobkowitz; Michael Kindermann; Einat Birk; Merav Birk; Mitja Lainscak; Dirk Foell; Philipp M. Lepper; Robert Bals; Marcin Krawczyk; Dror Mevorach; Tal Hasin; Andre Keren; Michael Kabesch; Hashim Abdul-Khaliq; Sigrun Smola; Moritz Bewarder; Bernhard Thurner; Michael Böhm; Jochen Pfeifer; Karin Klingel

Journal ArticleOPEN ACCESS

IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination

Thurner L
Kessel C
Fadle N
et al.

New England Journal of Medicine (2022) 387(16) 1524-1527

DOI: 10.1056/nejmc2205667

69Citations

57Readers

Abstract

neutralizing autoantibod- ies targeting the endogenous interleukin-1 recep- tor antagonist (IL-1RA), which inhibits interleu- kin-1 signaling and inflammation.

Cite

CITATION STYLE

APA

Thurner, L., Kessel, C., Fadle, N., Regitz, E., Seidel, F., Kindermann, I., … Klingel, K. (2022). IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination. New England Journal of Medicine, 387(16), 1524–1527. https://doi.org/10.1056/nejmc2205667

IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination

Abstract

Cite

Register to see more suggestions